In this episode of SPAC #Edge, Mark Yusko speaks to a SPAC sponsor and the CEO of a company that went public via a SPAC. Laura Niklason, MD., PhD., founder and CEO of Humacyte, a clinical-stage biotechnology platform company, and Rajiv Shukla, CEO of Alpha Healthcare Acquisition Corp, provide their unique perspective of the SPAC process from each side of the SPAC structure. Humacyte, a first-in-class business and the ideal type of business for a SPAC, recently completed a merger with Alpha HealthCare’s SPAC.   You’ll hear about their experience around the SPAC merger process and how science fiction, in their experience, truly became science fact.   To learn more about SPACs, Morgan Creek, and the investment solutions we offer, visit us on the web at https://www.morgancreekcap.com or contact us at [email protected].